Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > J Eric Ende > Profile

J Eric Ende

Affiliations

Director at Avadel Pharmaceuticals Plc (AVDL), 2025-01-14
Director at Matinas Biopharma Holdings Inc. (MTNB), 2023-11-03
Director at Neubase Therapeutics Inc. (NBSE), 2022-09-12
Director at Progenics Pharmaceuticals Inc (PGNX), 2020-06-23
Director at Genzyme Corp (GENZ), 2011-04-06

Insider Trading: Purchases See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
AVDL	$7.84	30,000	$235,218.00	208,900	2025-01-13	Filing
AVDL	$13.93	13,000	$181,100.40	167,900	2023-05-18	Filing
AVDL	$7.80	20,000	$156,050.00	154,900	2022-11-22	Filing
AVDL	$2.27	20,000	$45,496.00	134,900	2022-06-01	Filing
AVDL	$2.16	15,000	$32,394.00	114,900	2022-05-31	Filing